In December of 2024, I identified OraSure Technologies (NASDAQ: OSUR ) as undervalued with relatively low-risk given its robust balance sheet. Since then, OSUR has gotten even cheaper amidst increased market scrutiny of the healthcare sector. The** Comments are my own (not my firm's) and no one else's**I worked for many years at an investment firm where I invested across public and private market opportunities. I underwrote fund managers, as well as individual securities. I left the firm to pursue an MBA fr ...

OraSure Technologies (OSUR) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -20%. A quarter ago, it was expected that this diagnostic test maker would post a loss of $0.02 per share when it actually produced a loss of $0.06, delivering a surprise of -200%. Over the last four quarters, th ...

OraSure (OSUR) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants Jason Plagman - VP - Investor RelationsCarrie Manner - President & Chief Executive OfficerKenneth McGrath - Chief Financial OfficerNoah Lewis - Equity Research Associate Conference Call Participants None - Analyst Operator Good day, and thank you for standing by. Welcome to the OraSure Technologies, Inc. Twenty twenty five First Quarter Earnings Conference Call. At this time, all participants are in a listen only mode. After ...

OraSure (OSUR) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Speaker0 Good day, and thank you for standing by. Welcome to the OraSure Technologies, Inc. Twenty twenty five First Quarter Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Jason Plagman, Vice President of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ FORM 10-Q ______________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________to _________ . Commission File Number 001-16537 ____ ...

EXHIBIT 99.1 Investor Contact: Media Contact: Jason Plagman Amy Koch investorinfo@orasure.com media@orasure.com VP, Investor Relations Director, Corporate Communications OraSure Announces First Quarter 2025 Financial Results BETHLEHEM, PA, May 7, 2025 (GLOBE NEWSWIRE) – OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended March 31, 2025. "Our Q1 results were consistent ...

"Our Q1 results were consistent with our expectations. Our customers continue to demonstrate their preference for our differentiated products in delivering on their important health objectives, even while uncertainty remains elevated related to government funding sources for some segments," said OraSure President and CEO Carrie Eglinton Manner. "We are making good progress in advancing our innovation roadmap, including multiple new product milestones planned in 2025, and OTI is positioned to deliver acceler ...

I last wrote about OraSure Technologies (NASDAQ: OSUR ) in November of 2024. At the time, the company's shares were trading at roughly $4 a share. Since then, OSUR has dipped to below $3 per share (at the time of this writing). In this article, we will touchI am a value investor with a concentrated portfolio, focusing on rare and exceptional buying opportunities. As a keen reader of Value Investing literature, I am well versed in the teachings of 'super investors' such as Warren Buffett, Charlie Munger, Ben ...

BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET on May 7, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 mi ...

BETHLEHEM, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (the "Company") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that its Board of Directors has authorized the repurchase of up to $40 million of its common stock over the next twenty-four months, which will be funded from cash on hand. The Company may repurchase the shares through various methods in compliance with applicable state and federal securities laws. Th ...